Tenax Therapeutics Inc expected to post a loss of 10 cents a share - Earnings Preview

Tenax Therapeutics

07/08/2023 21:47

* Tenax Therapeutics Inc  TENX.OQ   TENX.O  is expected
to show no
change in quarterly revenue when it reports  results on August 9
(estimated). 
    * 
    * ​Refinitiv's mean analyst estimate for Tenax Therapeutics
Inc is
for a loss of 10 cents per share. 
    * The one available analyst rating on the shares is "buy".  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Tenax
Therapeutics Inc is $5.5​, above​ its last closing price
of $0.29. ​​​

This summary was machine generated August 7 at 20:46 GMT.  All
figures in US dollars  unless otherwise stated